Regional · UK & Ireland

Pharmacy supply in the UK and the questions you will be asked

Regional › UK & Ireland personal import cost per milligram MHRA NHS

c.marchettiTL2 Moderator31 Dec 2025#1

On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion.

A coverage question with the paperwork detail included, since that is what determines the answer.

Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which is the useful thing about a well-written denial.

Before I spend a week on it: is my reading of the stated criterion correct, and is there a documented precedent for this specific ground?

2 likes 7mo

c.balogunTL2 Moderator3 Jan 2026#2

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

5 likes 7mo

r.marsdenTL3Regular4 Jan 2026#3

c.marchetti, post #1: On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit… Go to post

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

14 likes in reply to #1 7mo

n.serranoTL2 Moderator6 Jan 2026#4

On post #2 — agreed on the reasoning, with one qualification.

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

29 likes 7mo

PSundbergTL2Member7 Jan 2026#5

Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management.

0 likes 7mo

f.fontaineTL2 Moderator9 Jan 2026#6

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

2 likes 7mo

sterile_tableTL3Regular10 Jan 2026 · edited#7

r.marsden, post #3: NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria. Go to post

post #6 is right about the mechanism and I think understates the practical bit.

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

9 likes in reply to #3 7mo

y.eriksenTL2 Moderator12 Jan 2026#8

Worth separating two things that post #4 runs together.

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

22 likes 6mo

curious_readerTL113 Jan 2026#9

Collapsed as off-topic by two members at trust level 3 or above

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

m.ramosTL2 Moderator14 Jan 2026#10

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

14 likes 6mo

b.jankowiakTL3Regular15 Jan 2026#11

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

21 likes 6mo

r.mensahTL2 Moderator16 Jan 2026#12

b.jankowiak, post #11: Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

9 likes in reply to #11 6mo

bench_entryTL3Regular18 Jan 2026#13

y.eriksen, post #8: Worth separating two things that post #4 runs together. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI. Go to post

Coming back to post #11, because the follow-up matters more than the original answer.

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

1 like in reply to #8 6mo

p.dialloTL2 Moderator19 Jan 2026#14

Picking up post #11: that is the part I would want checked first.

Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.

0 likes 6mo

slow_titratorTL2Regular20 Jan 2026#15

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

29 likes 6mo

t.karlsenTL2 Moderator21 Jan 2026#16

bench_entry, post #13: Coming back to post #11, because the follow-up matters more than the original answer. Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed. Go to post

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

14 likes in reply to #13 6mo

y.mensahTL3Wiki editor22 Jan 2026#17

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

2 likes 6mo

h.espinozaTL2 Moderator23 Jan 2026#18

This follows post #15 rather than contradicting it.

0 likes 6mo

journalclub_wrenTL3Regular24 Jan 2026#19

y.mensah, post #17: MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs. Go to post

On post #15 — agreed on the reasoning, with one qualification.

0 likes in reply to #17 6mo

ro.friskTL2 Moderator25 Jan 2026#20

p.diallo, post #14: Picking up post #11: that is the part I would want checked first. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

20 likes in reply to #14 6mo

e.ferreiraTL3Regular26 Jan 2026#21

post #20 is right about the mechanism and I think understates the practical bit.

7 likes 6mo

c.wijnbergTL2Member27 Jan 2026#22

Worth separating two things that post #18 runs together.

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

17 likes 6mo

r.bakkenTL2 Moderator28 Jan 2026#23

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

0 likes 6mo

n.rowntreeTL3Regular29 Jan 2026#24

t.karlsen, post #16: Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages. Go to post

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

0 likes in reply to #16 6mo

s.zamoraTL2 Moderator30 Jan 2026#25

post #24 answers the question as asked. The question underneath it is different.

4 likes 6mo

d.szymanskiTL3Wiki editor31 Jan 2026#26

12 likes 6mo

j.restrepoTL2 Moderator1 Feb 2026#27

slow_titrator, post #15: Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI. Go to post

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

25 likes in reply to #15 6mo

KAnderssonTL3Regular2 Feb 2026#28

c.wijnberg, post #22: Worth separating two things that post #18 runs together. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk. Go to post

Coming back to post #26, because the follow-up matters more than the original answer.

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

0 likes in reply to #22 6mo

t.ibarraTL2 Moderator3 Feb 2026#29

r.bakken, post #23: Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

1 like in reply to #23 6mo

IsaksenTL3Regular4 Feb 2026#30

7 likes 6mo

Sponsored Sigma-Aldrich — certified reference materialsReference standards, analytical reagents and certified materials for method calibration. If you are validating a method, this is where the standard comes from.Reference standards →